PALM2AKAP2 and non-small cell lung carcinoma: Duncavage and colleagues[11] investigated the expression of paralemmin-2 in non-small cell lung carcinomas because it is a potential target of the microRNA-221, which they showed to be down regulated in nonrecurrent tumors.